These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 8080716
21. Differential thermal sensitivity of tumour and normal tissue microvascular response during hyperthermia. Brown SL, Hunt JW, Hill RP. Int J Hyperthermia; 1992; 8(4):501-14. PubMed ID: 1402130 [Abstract] [Full Text] [Related]
22. Antitumor effects due to irreversible stoppage of tumor tissue blood flow: evaluation of a novel combretastatin A-4 derivative, AC7700. Hori K, Saito S, Nihei Y, Suzuki M, Sato Y. Jpn J Cancer Res; 1999 Sep; 90(9):1026-38. PubMed ID: 10551334 [Abstract] [Full Text] [Related]
23. Effects of two tumor blood flow modifiers, hydralazine and flavone acetic acid, on KHT tumours and normal tissues in mice. Honess DJ, Bleehen NM. Int J Radiat Biol; 1991 Sep; 60(1-2):249-53. PubMed ID: 1677979 [No Abstract] [Full Text] [Related]
24. Continuous and non-invasive quantification of heat-induced changes in blood flow in the skin and RIF-1 tumour of mice by laser Doppler flowmetry. Song CW, Rhee JG, Haumschild DJ. Int J Hyperthermia; 1987 Sep; 3(1):71-7. PubMed ID: 2951450 [Abstract] [Full Text] [Related]
25. The energy metabolism of RIF-1 tumours following hydralazine. Bhujwalla ZM, Tozer GM, Field SB, Maxwell RJ, Griffiths JR. Radiother Oncol; 1990 Nov; 19(3):281-91. PubMed ID: 2281156 [Abstract] [Full Text] [Related]
26. Comparative effects of hydralazine on perfusion of KHT tumor, kidney and liver and on renal function in mice. Honess DJ, Bleehen NM. Int J Radiat Oncol Biol Phys; 1992 Nov; 22(5):953-61. PubMed ID: 1555988 [Abstract] [Full Text] [Related]
27. Effect of photodynamic therapy on RIF-1 tumor metabolism and blood flow examined by 31P and 2H NMR spectroscopy. Mattiello J, Evelhoch JL, Brown E, Schaap AP, Hetzel FW. NMR Biomed; 1990 Apr; 3(2):64-70. PubMed ID: 2390455 [Abstract] [Full Text] [Related]
35. Size dependence of regional blood flow in murine tumours using deuterium magnetic resonance imaging. Larcombe-McDouall JB, Mattiello J, McCoy CL, Simpson NE, Seyedsadr M, Evelhoch JL. Int J Radiat Biol; 1991 Apr; 60(1-2):109-13. PubMed ID: 1677956 [No Abstract] [Full Text] [Related]
36. Residence time distributions of various tracers in tumors: implications for drug delivery and blood flow measurement. Eskey CJ, Wolmark N, McDowell CL, Domach MM, Jain RK. J Natl Cancer Inst; 1994 Feb 16; 86(4):293-9. PubMed ID: 8158684 [Abstract] [Full Text] [Related]
38. Acute effects of tumor necrosis factor alpha or lymphotoxin on global blood flow, laser Doppler flux, and bioenergetic status of subcutaneous rodent tumors. Kluge M, Elger B, Engel T, Schaefer C, Seega J, Vaupel P. Cancer Res; 1992 Apr 15; 52(8):2167-73. PubMed ID: 1559220 [Abstract] [Full Text] [Related]
39. High-resolution assessment of blood flow in murine RIF-1 tumors by monitoring uptake of H(2)(17)O with proton T(1rho)-weighted imaging. Tailor DR, Poptani H, Glickson JD, Leigh JS, Reddy R. Magn Reson Med; 2003 Jan 15; 49(1):1-6. PubMed ID: 12509813 [Abstract] [Full Text] [Related]
40. Histological evidence for nonperfused vasculature in a murine tumor following hydralazine administration. Trotter MJ, Acker BD, Chaplin DJ. Int J Radiat Oncol Biol Phys; 1989 Oct 15; 17(4):785-9. PubMed ID: 2777668 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]